vimarsana.com

Prevencio announced the culminative presentation of patient data demonstrating that its artificial intelligence (AI)-driven HART ® blood tests are highly accurate in a broad range of patients, including those with diabetes, chronic kidney disease, hypertension, obesity, coronary heart disease, heart failure, chronic total occlusion (CTO) of the heart arteries, and Kawasaki disease. The HART platform is disease agnostic and may be used to develop diagnostics beyond

Related Keywords

Massachusetts ,United States ,Jamesl Januzzi , ,Baim Institute For Clinical Research ,Professor Of Medicine At Harvard Medical School ,Industry News ,Massachusetts General Hospital ,Harvard Medical School ,Biomarker Trials ,Baim Institute ,Clinical Research ,Principal Investigator ,Revolutionary Diagnostic Hart Blood Tests And Platform By Prevencio Aacc ,Cdlm ,Hi ,Iagnostic ,Blood Test ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.